Clinica Baviera (FRA:D9Z) FFO


FRA:D9Z Clinica Baviera SA FRA:D9Z
99 GF Score
Price €55.80
GF Value €41.30
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Clinica Baviera FFO?

FFO (Funds from operations) only applies to REITs.

FRA:D9Z
99GF Score
Clinica Baviera SA FRA:D9Z
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Clinica Baviera (FRA:D9Z) Overvalued in 2026?

Based on GuruFocus' analysis, Clinica Baviera stock appears to be overvalued. The current stock price of €55.80 is trading 35.1% above its estimated GF Value™ of €41.30. GuruFocus considers Clinica Baviera to be Significantly Overvalued.

Key valuation signals for FRA:D9Z:

  • FFO:
  • GF Value™: €41.30 vs. price of €55.80 (35.1% above fair value)
  • GF Score™: 99/100 with 4 warning signs

No single metric tells the full story. See the FRA:D9Z stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Clinica Baviera Business Description

Address Paseo de la Castellana 20, Madrid, ESP, 28046
Clinica Baviera SA operates ophthalmological clinics. It is involved in the diagnosis, treatment, and monitoring of various types of ophthalmological disorders. It offers diagnosis and treatment for various eye problems such as long-sightedness, short-sightedness, astigmatism, cataracts and eye strain.
99GF Score

Get the complete analysis for FRA:D9Z

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€55.80
Price
€41.30
GF Value